• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

沙特阿拉伯一家三级保健机构感染的流行病学:前瞻性监测结果。

Epidemiology of infection at a tertiary care facility in Saudi Arabia: Results of prospective surveillance.

机构信息

From the Infection Control and Prevention Centre of Excellence (Kaabia, Al Basha, Bukhari, Bouafia, Al Qahtani, Aboushanab, Al Odayani), Prince Sultan Military Medical City, and from the Department of specialty? (Alshahrani), Al Maarefa University, Riyadh, Kingdom of Saudi Arabia.

出版信息

Saudi Med J. 2024 Feb;45(2):188-193. doi: 10.15537/smj.2024.45.2.20230398.

DOI:10.15537/smj.2024.45.2.20230398
PMID:38309732
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11115418/
Abstract

OBJECTIVES

To determine the incidence of infection (CDI) and the frequency of known risk factors.

METHODS

A prospective hospital-based surveillance for CDI, according to the Centers for Disease Control and Prevention criteria, was carried out from July 2019 to March 2022 for all inpatients aged more than one year in Prince Sultan Military Medical City, Riyadh, Saudi Arabia.

RESULTS

A total of 139 cases of CDI were identified during the survey among 130 patients admitted in the hospital. Most cases were incident (n=130; 93.5%), and almost three-quarters (n=102; 73.4%) were hospital-onset (HO) CDI, with an incidence rate of 1.62 per 10,000 patient days (PD). The highest rates were noted in intensive care units with an incidence rate of 3 per 10,000 PD and wards for immunocompromised patients with an incidence rate of 2.72 per 10,000 PD. The most prevalent risk factor for CDI was acid-reducing drugs (72.6%). Vancomycin (48%) and ciprofloxacin (25%) were the most frequently prescribed antibiotics for patients with CDI. infection complications were identified in 5.7% of the cases, with a reported 28-day mortality rate of 3.8%.

CONCLUSION

In our hospital, HO-CDI incidence rate is lower than that in high-income countries. National multicenter surveillance is needed to evaluate the actual burden of CDI in Saudi Arabia.

摘要

目的

确定感染(CDI)的发生率和已知危险因素的频率。

方法

根据美国疾病控制与预防中心的标准,对 2019 年 7 月至 2022 年 3 月在沙特阿拉伯利雅得的苏尔坦亲王军事医疗城的所有 1 岁以上住院患者进行了 CDI 的前瞻性基于医院的监测。

结果

在本次调查中,在医院住院的 130 名患者中发现了 139 例 CDI 病例。大多数病例为偶发性(n=130;93.5%),近四分之三(n=102;73.4%)为医院获得性(HO)CDI,发病率为每 10000 患者日(PD)1.62 例。发病率最高的是重症监护病房,发病率为每 10000 PD 3 例,免疫功能低下患者病房发病率为每 10000 PD 2.72 例。CDI 最常见的危险因素是胃酸抑制药物(72.6%)。万古霉素(48%)和环丙沙星(25%)是 CDI 患者最常开的抗生素。5.7%的病例出现 CDI 并发症,报告的 28 天死亡率为 3.8%。

结论

在我们医院,HO-CDI 的发病率低于高收入国家。需要进行全国多中心监测,以评估 CDI 在沙特阿拉伯的实际负担。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c9e5/11115418/06961ca78707/SaudiMedJ-45-2-188_3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c9e5/11115418/03bc90d360dd/SaudiMedJ-45-2-188_1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c9e5/11115418/6582e448b8b6/SaudiMedJ-45-2-188_2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c9e5/11115418/06961ca78707/SaudiMedJ-45-2-188_3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c9e5/11115418/03bc90d360dd/SaudiMedJ-45-2-188_1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c9e5/11115418/6582e448b8b6/SaudiMedJ-45-2-188_2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c9e5/11115418/06961ca78707/SaudiMedJ-45-2-188_3.jpg

相似文献

1
Epidemiology of infection at a tertiary care facility in Saudi Arabia: Results of prospective surveillance.沙特阿拉伯一家三级保健机构感染的流行病学:前瞻性监测结果。
Saudi Med J. 2024 Feb;45(2):188-193. doi: 10.15537/smj.2024.45.2.20230398.
2
Clostridioides difficile infection: Incidence and risk factors in a tertiary care facility in Riyadh, Saudi Arabia.艰难梭菌感染:在沙特阿拉伯利雅得的一家三级保健机构的发生率和危险因素。
J Infect Public Health. 2020 Jul;13(7):1012-1017. doi: 10.1016/j.jiph.2019.10.014. Epub 2019 Dec 9.
3
Clostridioides (Clostridium) difficile-associated disease: Epidemiology among patients in a general hospital in Saudi Arabia.艰难梭菌(梭状芽孢杆菌)相关疾病:沙特阿拉伯一家综合医院患者中的流行病学情况。
Am J Infect Control. 2020 Oct;48(10):1152-1157. doi: 10.1016/j.ajic.2020.01.011. Epub 2020 Feb 29.
4
Surveillance and epidemiology of Clostridioides difficile infection using the national health surveillance network criteria: A 7-year study from Mumbai, India.利用国家卫生监测网络标准对艰难梭菌感染进行监测和流行病学研究:来自印度孟买的一项 7 年研究。
Indian J Med Microbiol. 2023 Nov-Dec;46:100425. doi: 10.1016/j.ijmmb.2023.100425. Epub 2023 Jul 12.
5
An insight into -associated diarrhea in Saudi children: diagnosis and treatment.沙特儿童相关腹泻的深入研究:诊断与治疗
Expert Rev Gastroenterol Hepatol. 2023 Jul-Dec;17(8):805-810. doi: 10.1080/17474124.2023.2240704. Epub 2023 Jul 26.
6
Cost and length of hospital stay for healthcare facilityonset Clostridioides Difficile infection in pediatric wards: a prospective cohort analysis.医疗机构相关性艰难梭菌感染患儿住院费用及住院时间的前瞻性队列分析。
Turk J Pediatr. 2021;63(6):1004-1011. doi: 10.24953/turkjped.2021.06.008.
7
The Effect of Saccharomyces boulardii Primary Prevention on Risk of Hospital-onset Clostridioides difficile Infection in Hospitalized Patients Administered Antibiotics Frequently Associated With C. difficile Infection.布拉氏酵母菌预防治疗对频繁使用易致艰难梭菌感染抗生素的住院患者艰难梭菌医院感染发病率的影响。
Clin Infect Dis. 2021 Nov 2;73(9):e2512-e2518. doi: 10.1093/cid/ciaa808.
8
Epidemiology and Outcomes of Patients With Healthcare Facility-Onset Clostridioides difficile Infection.医疗机构获得性艰难梭菌感染患者的流行病学和结局。
Mil Med. 2022 Jul 1;187(7-8):e915-e920. doi: 10.1093/milmed/usab116.
9
Effectiveness of Oral Vancomycin for Prevention of Healthcare Facility-Onset Clostridioides difficile Infection in Targeted Patients During Systemic Antibiotic Exposure.口服万古霉素预防系统性抗生素暴露期间目标患者发生医疗机构获得性艰难梭菌感染的效果。
Clin Infect Dis. 2020 Aug 22;71(5):1133-1139. doi: 10.1093/cid/ciz966.
10
Increase of healthcare-onset Clostridioides difficile infection in adult population since SARS-CoV-2 pandemic: A retrospective cohort study in a tertiary care hospital from 2019 to 2022.自 SARS-CoV-2 大流行以来,成人 healthcare-onset 艰难梭菌感染增加:2019 年至 2022 年在一家三级保健医院进行的回顾性队列研究。
Anaerobe. 2024 Apr;86:102836. doi: 10.1016/j.anaerobe.2024.102836. Epub 2024 Feb 28.

引用本文的文献

1
The Global Burden of Infections, 2016-2024: A Systematic Review and Meta-Analysis.2016 - 2024年全球感染负担:系统评价与荟萃分析
Infect Dis Rep. 2025 Apr 14;17(2):31. doi: 10.3390/idr17020031.

本文引用的文献

1
The Positive Association between Proton Pump Inhibitors and Clostridium Difficile Infection.质子泵抑制剂与艰难梭菌感染之间的正相关关系。
Innov Pharm. 2021 Mar 9;12(1). doi: 10.24926/iip.v12i1.3439. eCollection 2021.
2
Antibiotics and healthcare facility-associated Clostridioides difficile infection: systematic review and meta-analysis 2020 update.抗生素与医疗保健机构相关的艰难梭菌感染:系统评价和荟萃分析 2020 更新。
J Antimicrob Chemother. 2021 Jun 18;76(7):1676-1688. doi: 10.1093/jac/dkab091.
3
infection in an academic medical center in Saudi Arabia: prevalence and risk factors.
沙特阿拉伯一学术医疗中心的感染:流行率和风险因素。
Ann Saudi Med. 2020 Jul-Aug;40(4):305-309. doi: 10.5144/0256-4947.2020.305. Epub 2020 Aug 6.
4
Incidence of Clostridioides difficile infection at a Saudi Tertiary Academic Medical Center and compliance with IDSA/SHEA, ACG, and ESCMID guidelines for treatment over a 10-year period.在沙特阿拉伯一家三级学术医疗中心,艰难梭菌感染的发生率,以及在过去 10 年中遵循 IDSA/SHEA、ACG 和 ESCMID 指南进行治疗的情况。
J Infect Public Health. 2020 Aug;13(8):1156-1160. doi: 10.1016/j.jiph.2020.03.007. Epub 2020 Apr 8.
5
Clostridioides (Clostridium) difficile-associated disease: Epidemiology among patients in a general hospital in Saudi Arabia.艰难梭菌(梭状芽孢杆菌)相关疾病:沙特阿拉伯一家综合医院患者中的流行病学情况。
Am J Infect Control. 2020 Oct;48(10):1152-1157. doi: 10.1016/j.ajic.2020.01.011. Epub 2020 Feb 29.
6
Clostridioides difficile infection: Incidence and risk factors in a tertiary care facility in Riyadh, Saudi Arabia.艰难梭菌感染:在沙特阿拉伯利雅得的一家三级保健机构的发生率和危险因素。
J Infect Public Health. 2020 Jul;13(7):1012-1017. doi: 10.1016/j.jiph.2019.10.014. Epub 2019 Dec 9.
7
Hospital-level high-risk antibiotic use in relation to hospital-associated infections: Retrospective analysis of 2016-2017 data from US hospitals.医院级别高风险抗生素使用与医院相关性感染的关系:来自美国医院 2016-2017 年数据的回顾性分析。
Infect Control Hosp Epidemiol. 2019 Nov;40(11):1229-1235. doi: 10.1017/ice.2019.236. Epub 2019 Sep 16.
8
infection and antibiotic-associated diarrhoea.感染和抗生素相关性腹泻。
Clin Med (Lond). 2018 Jun;18(3):237-241. doi: 10.7861/clinmedicine.18-3-237.
9
Risk factors for infections - an overview of the evidence base and challenges in data synthesis.感染的危险因素——证据基础概述及数据综合的挑战。
J Glob Health. 2017 Jun;7(1):010417. doi: 10.7189/jogh.07.010417.
10
Comparison of the Hospital-Acquired Infection Risk of Using Proton Pump Inhibitors versus Histamine-2 Receptor Antagonists for Prophylaxis and Treatment of Stress Ulcers: A Systematic Review and Meta-Analysis.质子泵抑制剂与组胺 2 受体拮抗剂用于预防和治疗应激性溃疡的医院获得性感染风险比较:系统评价和荟萃分析。
Gut Liver. 2017 Nov 15;11(6):781-788. doi: 10.5009/gnl16568.